Physician profile
Jan Kriska
NPI 1104823327
$5,538.56
in general payments reported to CMS, 2019-2025
36 companies · $639 in 2025
The $639 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $414 · 2021: $474 · 2022: $1,013 · 2023: $1,126 · 2024: $1,231 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,995.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,091.28 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Jazz Pharmaceuticals INC. | $809.74 | 2019-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $410.16 | 2024-2025 | Lumryz |
| Glaxosmithkline, LLC. | $408.55 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Harmony Biosciences LLC | $399.62 | 2020-2024 | Wakix |
| Amgen INC. | $318.67 | 2019-2024 | Repatha, Otezla |
| Novo Nordisk INC | $245.87 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Axsome Therapeutics, INC. | $232.10 | 2022-2025 | Sunosi |
| Merck Sharp & Dohme LLC | $172.16 | 2019-2022 | |
| Mylan Specialty L.P. | $159.90 | 2019-2024 | Yupelri |
| Pfizer INC. | $159.62 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.08 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $129.61 | 2019-2024 | Mounjaro, Emgality, Jardiance |
| Sanofi-Aventis U.S. LLC | $112.26 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $96.13 | 2022-2023 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Kriska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.